Efficacy studies of malaria treatments in Africa: Efficient estimation with missing indicators of failure

Statistical Methods in Medical Research

Volumn 17, Issue 2, 2008, Pages 191-206

  Machekano, Rhoderick N ^a   Dorsey, G ^b   Hubbard, A ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE; CHLOROQUINE; FANSIDAR;

AFRICA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MAXIMUM LIKELIHOOD METHOD; OUTCOME ASSESSMENT; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ANTIMALARIALS; HUMANS; MALARIA; MODELS, THEORETICAL; UGANDA;

EID: 43949144188     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280207078202     Document Type: Article

References (15)

1. Wood Angela M, White Ian R, Thompson Simon G. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clinical Trials 2004; 1: 368-76.
2. Mealli Fabrizia, Rubin Donald B. Assumptions when analyzing randomized experiments with noncompliance and missing outcomes. Health Services & Outcomes Research Methodogy 2002; 3: 225-32.
3. Little Roderick J A, Rubin Donald B. Statistical analysis with missing data. John Wiley & Sons; 2002.
4. Rubin Donald B. Inference and missing data. Biometrika 1976; 63: 581-90.
5. Rotnitzky Andrea, Robins James M, Scharfstein Daniel O. Semiparametric regression for repeated outcomes with nonignorable nonresponse. Journal of the American Statistical Association 1998; 93: 1321-39.
6. Slater M, Kiggundu M, Dokomajilar C, Kamya MR, Bakyaita N, Talisuna A, et al. Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. American Journal of Tropical Medicine and Hygiene 2005; 73(2): 256-62.
7. Snounou G, Beck HP. The use of PCR-genotyping in the assessment of recrudesence or reinfection after antimalarial drug treatment. Parasitology Today 1998; 14: 462-67.
8. Frangakis Constantine E, Rubin Donald B. Principal stratification in causal inference. Biometrics 2002; 58(1): 21-29.
9. Schafer Joseph L. Multiple Imputation: A Primer. Statistical Methods in Medical Research 1999; 8: 3-15.
10. van der Laan Mark J, Robins James M. Unified methods for censored longitudinal data and causality. Springer; 2002.
11. Robins James, Rotnitzky Andrea. Estimation of treatment effects in randomised trials with non-compliance and a dichotomous outcome using structural mean models. Biometrika 2004; 91(4): 763-83.
12. Robins James M. Comment on "using inverse weighting and predictive inference to estimate the effects of time-varying treatments on the discrete-time hazard" (1641-1661). Statistics in Medicine 2002; 21(12): 1663-80.
13. Scharfstein Daniel O, Robins James M. Estimation of the failure time distribution in the presence of informative censoring. Biometrika 2002; 89(3): 617-34.
14. Scharfstein Daniel O, Irizarry Rafael A. Generalized additive selection models for the analysis of studies with potentially nonignorable missing outcome data. Biometrics 2003; 59(3): 601-13.
15. Scharfstein Daniel O, Rotnitzky Andrea, Robins James M. Adjusting for nonignorable drop-out using semiparametric nonresponse models (C/R: P1121-1146). Journal of the American Statistical Association 1999; 94: 1096-1120.